JAMIE H. CORRO • Division of Genetics, Wadsworth Center, New York State Department of
Health, Albany, NY, USA; Department of Biomedical Sciences, University at Albany,
Albany, NY, USA
JONATHAN A. G. COX • School of Life and Health Sciences, Aston University, Birmingham,
UK
MAMADOU DAFFE ´ • Tuberculosis & Infection Biology Department, Institut de Pharmacologie
et de Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS),
Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier (Toulouse III), Toulouse,
France
VE ´ RONIQUE DARTOIS • Center for Discovery and Innovation, Hackensack Meridian Health,
Nutley, NJ, USA
NATHALIE DEBOOSERE • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
Center for Infection and Immunity of Lille (CIIL), Lille Cedex, France
YONATAN N. DEGEFU • Department of Molecular Biology and Microbiology and Stuart B.
Levy Center for Integrated Management of Antimicrobial Resistance, Tufts University
School of Medicine, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard
Medical School, Boston, MA, USA
NEERAJ DHAR • School of Life Sciences, Swiss Federal Institute of Technology in Lausanne
(EPFL), Lausanne, Switzerland
KAREN M. DOBOS • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
KALA EARLY • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
JESSICA FARROW-JOHNSON • Department of Microbiology, University of Washington, Seattle,
WA, USA
ANDREW M. FRANK • ATCC, Manassas, VA, USA
DAVID GIACALONE • Department of Molecular Biology and Microbiology, Tufts University
School of Medicine, Boston, MA, USA; Graduate Program in Molecular Microbiology,
Graduate School of Biomedical Sciences, Tufts University, Boston, MA, USA
SAVANNAH E. R. GIBSON • School of Life and Health Sciences, Aston University, Birmingham,
UK
NATALIE S. GLEASON • Department of Microbiology, University of Washington, Seattle, WA,
USA
BEN GOLD • Department of Microbiology and Immunology, Weill Cornell Medicine, New
York, NY, USA
SAMUEL R. GREENFIELD • ATCC, Manassas, VA, USA
NABIL HANNA • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
JAMES HARRISON • School of Life and Health Sciences, Aston University, Birmingham, UK
MANZOUR HERNANDO HAZBO ´ N • ATCC, BEI Resources, Manassas, VA, USA
DEBRA HENDRICKSON • ATCC/BEI Resources, Manassas, VA, USA
EIK HOFFMANN • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Center
for Infection and Immunity of Lille (CIIL), Lille Cedex, France
LU HUANG • Department of Microbiology and Immunology, University of Arkansas for
Medical Sciences, Little Rock, AR, USA
DEBORAH T. HUNG • Broad Institute of MIT and Harvard, Cambridge, MA, USA;
Department of Molecular Biology and Center for Computational and Integrative Biology,
xii
Contributors
Health, Albany, NY, USA; Department of Biomedical Sciences, University at Albany,
Albany, NY, USA
JONATHAN A. G. COX • School of Life and Health Sciences, Aston University, Birmingham,
UK
MAMADOU DAFFE ´ • Tuberculosis & Infection Biology Department, Institut de Pharmacologie
et de Biologie Structurale (IPBS), Centre National de la Recherche Scientifique (CNRS),
Toulouse, France; Universite ´ de Toulouse, Universite ´ Paul Sabatier (Toulouse III), Toulouse,
France
VE ´ RONIQUE DARTOIS • Center for Discovery and Innovation, Hackensack Meridian Health,
Nutley, NJ, USA
NATHALIE DEBOOSERE • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille,
Center for Infection and Immunity of Lille (CIIL), Lille Cedex, France
YONATAN N. DEGEFU • Department of Molecular Biology and Microbiology and Stuart B.
Levy Center for Integrated Management of Antimicrobial Resistance, Tufts University
School of Medicine, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard
Medical School, Boston, MA, USA
NEERAJ DHAR • School of Life Sciences, Swiss Federal Institute of Technology in Lausanne
(EPFL), Lausanne, Switzerland
KAREN M. DOBOS • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
KALA EARLY • Mycobacteria Research Laboratories, Department of Microbiology,
Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA
JESSICA FARROW-JOHNSON • Department of Microbiology, University of Washington, Seattle,
WA, USA
ANDREW M. FRANK • ATCC, Manassas, VA, USA
DAVID GIACALONE • Department of Molecular Biology and Microbiology, Tufts University
School of Medicine, Boston, MA, USA; Graduate Program in Molecular Microbiology,
Graduate School of Biomedical Sciences, Tufts University, Boston, MA, USA
SAVANNAH E. R. GIBSON • School of Life and Health Sciences, Aston University, Birmingham,
UK
NATALIE S. GLEASON • Department of Microbiology, University of Washington, Seattle, WA,
USA
BEN GOLD • Department of Microbiology and Immunology, Weill Cornell Medicine, New
York, NY, USA
SAMUEL R. GREENFIELD • ATCC, Manassas, VA, USA
NABIL HANNA • Department of Biochemistry, Faculty of Science, University of Geneva,
Geneva, Switzerland
JAMES HARRISON • School of Life and Health Sciences, Aston University, Birmingham, UK
MANZOUR HERNANDO HAZBO ´ N • ATCC, BEI Resources, Manassas, VA, USA
DEBRA HENDRICKSON • ATCC/BEI Resources, Manassas, VA, USA
EIK HOFFMANN • Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, Center
for Infection and Immunity of Lille (CIIL), Lille Cedex, France
LU HUANG • Department of Microbiology and Immunology, University of Arkansas for
Medical Sciences, Little Rock, AR, USA
DEBORAH T. HUNG • Broad Institute of MIT and Harvard, Cambridge, MA, USA;
Department of Molecular Biology and Center for Computational and Integrative Biology,
xii
Contributors